Evidence map›Paper›PMID 39563791›Full record

ArticleACS medicinal chemistry letters2024

1-Deoxynojirimycin Derivative Containing Tegafur Induced HCT-116 Cell Apoptosis through Mitochondrial Dysfunction and Oxidative Stress Pathway.

Liqing Tang, Yixing Xu, Jianglong He, Gaiqun Huang, Xueping Jiang, Yuqi Li, Hao Li, Ran Zhang, Zhongzheng Gui

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Molecules (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Liqing TangSchool of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu 212100, China.
Yixing XuSchool of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu 212100, China.
Jianglong HeSchool of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu 212100, China.
Gaiqun HuangSericultural Research Institute, Sichuan Academy of Agricultural Sciences, Nanchong, Sichuan 637000, China.
Xueping JiangSchool of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu 212100, China.
Yuqi LiSchool of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu 212100, China.
Hao LiSchool of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu 212100, China.
Ran ZhangSchool of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu 212100, China.ORCID https://orcid.org/0000-0003-3661-7785
Zhongzheng GuiSchool of Biotechnology, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu 212100, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three 1-deoxynojirimycin (DNJ) derivatives (named

Identifiers

PMID39563791
PMCPMC11571086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.